Wenqiang Yu

2.7k total citations
55 papers, 1.8k citations indexed

About

Wenqiang Yu is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Wenqiang Yu has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 21 papers in Cancer Research and 6 papers in Nephrology. Recurrent topics in Wenqiang Yu's work include Epigenetics and DNA Methylation (17 papers), RNA modifications and cancer (15 papers) and MicroRNA in disease regulation (12 papers). Wenqiang Yu is often cited by papers focused on Epigenetics and DNA Methylation (17 papers), RNA modifications and cancer (15 papers) and MicroRNA in disease regulation (12 papers). Wenqiang Yu collaborates with scholars based in China, United States and United Kingdom. Wenqiang Yu's co-authors include Huaibing Luo, Ying Liang, Shihua Dong, Lina Peng, Kai M. Schmidt‐Ott, Jonathan Barasch, Andong Qiu, Neal Paragas, Mélanie Viltard and Yanping Xi and has published in prestigious journals such as Nucleic Acids Research, Nature Medicine and Nature Communications.

In The Last Decade

Wenqiang Yu

52 papers receiving 1.7k citations

Peers

Wenqiang Yu
Yan He China
Yizhuo Wang China
Lu Liu China
Li Lin China
Eva Hamade Lebanon
Jia Fu China
Christoph Schell Germany
Xue-Jia Lin China
Moritz Haneklaus Ireland
Yan He China
Wenqiang Yu
Citations per year, relative to Wenqiang Yu Wenqiang Yu (= 1×) peers Yan He

Countries citing papers authored by Wenqiang Yu

Since Specialization
Citations

This map shows the geographic impact of Wenqiang Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenqiang Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenqiang Yu more than expected).

Fields of papers citing papers by Wenqiang Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenqiang Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenqiang Yu. The network helps show where Wenqiang Yu may publish in the future.

Co-authorship network of co-authors of Wenqiang Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenqiang Yu. A scholar is included among the top collaborators of Wenqiang Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenqiang Yu. Wenqiang Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Y.C., et al.. (2025). A Rigorous Nuclear DNA-Excluding Mass Spectrometry Assay for Accurate Identification of 5-Methylcytosine in Mitochondrial DNA. Analytical Chemistry. 97(11). 5914–5918. 2 indexed citations
2.
Yu, Wenqiang, et al.. (2024). Experimental Analysis of the Mechanical Properties and Failure Behavior of Deep Coalbed Methane Reservoir Rocks. Processes. 12(6). 1125–1125. 6 indexed citations
3.
4.
Xu, Peng, et al.. (2023). Pre-enriched saline gargle samples for detection of SARS-CoV-2. BioScience Trends. 17(1). 81–84. 1 indexed citations
5.
Zhu, Congcong, Ying Xue, Changhong Miao, et al.. (2023). A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer. British Journal of Cancer. 128(9). 1681–1689. 14 indexed citations
6.
7.
Gao, Ying, et al.. (2023). JMJD3 ablation in myeloid cells confers renoprotection in mice with DOCA/salt-induced hypertension. Hypertension Research. 46(8). 1934–1948. 7 indexed citations
8.
Liang, Ying, Guangdong Hou, Geng Zhang, et al.. (2022). FBP1/miR-24-1/enhancer axis activation blocks renal cell carcinoma progression via Warburg effect. Frontiers in Oncology. 12. 928373–928373. 13 indexed citations
9.
Chen, Lu, et al.. (2022). Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Molecular Biomedicine. 3(1). 15–15. 6 indexed citations
10.
Qi, Lu, Peng Xu, Chengyang Wang, et al.. (2022). Hypermethylated PCDHGB7 as a Biomarker for Early Detection of Endometrial Cancer in Endometrial Brush Samples and Cervical Scrapings. Frontiers in Molecular Biosciences. 8. 774215–774215. 12 indexed citations
11.
Gao, Ying, Wenqiang Yu, Jiping Liu, et al.. (2022). Pharmacological Inhibition of STING/TBK1 Signaling Attenuates Myeloid Fibroblast Activation and Macrophage to Myofibroblast Transition in Renal Fibrosis. Frontiers in Pharmacology. 13. 940716–940716. 22 indexed citations
12.
Liang, Ying, Lu Qi, Wei Li, et al.. (2021). Reactivation of tumour suppressor in breast cancer by enhancer switching through NamiRNA network. Nucleic Acids Research. 49(15). 8556–8572. 42 indexed citations
13.
Liang, Hua, et al.. (2021). Pharmacological inhibition of SETD7 by PFI-2 attenuates renal fibrosis following folic acid and obstruction injury. European Journal of Pharmacology. 901. 174097–174097. 20 indexed citations
14.
Yuan, Zheng, Peng Xu, Dapeng Zhang, et al.. (2020). An electroosmotic flow-free two-direction migration strategy enables fast affinity capillary electrophoresis to study the weak interactions between basic peptides and RNA. Analytical Methods. 12(48). 5833–5838. 3 indexed citations
15.
Dong, Shihua, Wei Li, Lin Wang, et al.. (2019). Histone-Related Genes Are Hypermethylated in Lung Cancer and Hypermethylated HIST1H4F Could Serve as a Pan-Cancer Biomarker. Cancer Research. 79(24). 6101–6112. 38 indexed citations
16.
Wang, Bei, Daqi Wang, Baolong Zhang, et al.. (2019). krCRISPR: an easy and efficient strategy for generating conditional knockout of essential genes in cells. Journal of Biological Engineering. 13(1). 35–35. 23 indexed citations
17.
Li, Jin, Wei Li, Huaibing Luo, et al.. (2019). Guide Positioning Sequencing identifies aberrant DNA methylation patterns that alter cell identity and tumor-immune surveillance networks. Genome Research. 29(2). 270–280. 28 indexed citations
18.
Liang, Ying, et al.. (2018). An epigenetic perspective on tumorigenesis: Loss of cell identity, enhancer switching, and NamiRNA network. Seminars in Cancer Biology. 57. 1–9. 21 indexed citations
19.
Luo, Huaibing, Yanping Xi, Wei Li, et al.. (2017). Cell identity bookmarking through heterogeneous chromatin landscape maintenance during the cell cycle. Human Molecular Genetics. 26(21). 4231–4243. 11 indexed citations
20.
Peng, Lina, et al.. (2013). Moving RNA moves RNA forward. Science China Life Sciences. 56(10). 914–920. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yan He Breakdown of academic impact, for papers by Yizhuo Wang Breakdown of academic impact, for papers by Lu Liu Breakdown of academic impact, for papers by Li Lin Breakdown of academic impact, for papers by Eva Hamade Breakdown of academic impact, for papers by Jia Fu Breakdown of academic impact, for papers by Christoph Schell Breakdown of academic impact, for papers by Xue-Jia Lin Breakdown of academic impact, for papers by Moritz Haneklaus
Rankless by CCL
2026